[Federal Register Volume 67, Number 48 (Tuesday, March 12, 2002)]
[Notices]
[Pages 11141-11142]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-5792]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on October 12, 2001, Chiragene, 
Inc., Technology Centre of New Jersey, 661 Highway One, North 
Brunswick, New Jersey 08902, made application by renewal to the Drug 
Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                             Drug                               Schedule
------------------------------------------------------------------------
N-Ethylamphetamine (1475)....................................          I
2,5-Dimethoxyamphetamine (7396)..............................          I
3,4-Methylenedioxyamphetamine (7400).........................          I
4-Methoxyamphetamine (7411)..................................          I
Amphetamine (1100)...........................................         II
Methylphenidate (1724).......................................         II
Morphine (9300)..............................................         II
Fentanyl (9801)..............................................         II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances to 
supply their customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.

[[Page 11142]]

    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than May 13, 2002.

    Dated: February 19, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-5792 Filed 3-11-02; 8:45 am]
BILLING CODE 4410-09-M